These 26 largest Massachusetts Health Care Companies have seen their equal-company-weighted average stock market prices increase by a very impressive 673% for the six years and three and a half months from March 6, 2009 through the most recent date June 19, 2015.
The US Supreme Court is finalizing its position on King vs Burwell. If it rules to eliminate health insurance premium subsidies in 34 US States, the economic result on US Citizen Stock Market Portfolios will be a huge haircut, especially since just these 26 largest Massachusetts Health Care Companies presently have a Total Stock Market Capitalization of $341 bil buoyed by the many additional health care customers in the Health Insurance Exchanges under the ACA, coupled with the fact that the average stock market price appreciation of these 26 largest Massachusetts Health Care Companies has been nearly 7 times since March 6, 2009.
Below here are stock market prices on the most recent date June 19, 2015, or on the date sold for the 3 Companies sold since 2014, and on March 6, 2009 for these 26 largest Massachusetts Headquartered Health Care Companies, along with the related Stock Market Price Percentage Changes. The Companies are presented by Stock Market Capitalization:
| Market | |||||
| Price | |||||
| % | |||||
| Change | |||||
| Market | Market | 3-6-09 | |||
| Price | Price | to | |||
| Health Care Companies | HQs | 6-19-15 | 3-6-09 | 6-19-15 | |
| $s | $s | ||||
| Massachusetts | |||||
| Biogen Idec | Cambridge | MA | 411.05 | 44.23 | 829% |
| Thermo Fisher Scientific | Waltham | MA | 129.97 | 34.16 | 280% |
| Covidien plc | Mansfield | MA | 107.45 | 25.48 | 322% |
| Vertex Pharmaceuticals | Cambridge | MA | 128.04 | 27.77 | 361% |
| Boston Scientific | Natick | MA | 17.84 | 6.33 | 182% |
| Alnylam Pharmaceuticals | Cambridge | MA | 136.36 | 15.79 | 764% |
| Hologic | Bedford | MA | 38.26 | 9.70 | 294% |
| Synageva BioPharma | Lexington | MA | 235.80 | 6.70 | 3419% |
| Cubist Pharmaceuticals | Lexington | MA | 102.00 | 14.67 | 595% |
| PerkinElmer | Waltham | MA | 53.90 | 11.52 | 368% |
| athenahealth | Watertown | MA | 119.88 | 26.66 | 350% |
| Alere | Waltham | MA | 51.66 | 21.97 | 135% |
| Dyax | Burlington | MA | 26.68 | 2.17 | 1129% |
| PAREXEL Intl | Waltham | MA | 70.60 | 7.95 | 788% |
| Idenix Pharmaceuticals | Cambridge | MA | 24.50 | 2.67 | 818% |
| Charles River Laboratories | Wilmington | MA | 73.67 | 25.12 | 193% |
| ABIOMED | Danvers | MA | 67.73 | 4.99 | 1257% |
| Haemonetics | Braintree | MA | 42.53 | 26.69 | 59% |
| AMAG Pharmaceuticals | Lexington | MA | 70.80 | 24.62 | 188% |
| Insulet | Bedford | MA | 31.09 | 3.36 | 825% |
| Ariad Pharmaceuticals | Cambridge | MA | 8.77 | 1.20 | 631% |
| ZIOPHARM Oncology | Boston | MA | 12.14 | 0.70 | 1634% |
| Momenta Pharmaceuticals | Cambridge | MA | 23.78 | 7.44 | 220% |
| Repligen | Waltham | MA | 39.75 | 3.73 | 966% |
| Sarepta Therapeutics | Cambridge | MA | 30.35 | 3.78 | 703% |
| ImmunoGen | Waltham | MA | 14.63 | 4.91 | 198% |
| Average % Change all 26 Massachusetts Health Care Companies With Market Cap > $1 Bil | 673% | ||||
